Study Title

Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer

Study Details

Description:

The purpose of this study is to evaluate the effectiveness and safety of 177Lu-PSMA-0057 in metastatic prostate cancer.

Sponsor:

Nanjing First Hospital, Nanjing Medical University

Contacts:

Feng Wang (Study Director)

fengwangcn@hotmail.com

02552271491

Government Study Link:

NCT06050239 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468